Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Progress in oral therapy of diabetes mellitus with sulphonylureas of the second generation.

× No keyword cloud information.

10 in total

1. [CLINICAL EXPERIENCE WITH ORAL THERAPY OF DIABETES MELLITUS].

Authors: H LEUBNER
Journal: Wien Klin Wochenschr Date: 1964-08-14 Impact factor: 1.704

2. [Comparative experiments on the morphology & hormonal content of calves' pancreas after the administration of sulfonyl urea (D 860)].

Authors: E F PFEIFFER; H STEIGERWALD; W SANDRITTER; A BANDER; A MAGER; U BECKER; K RETIENE
Journal: Dtsch Med Wochenschr Date: 1957-09-06 Impact factor: 0.628

3. [A new anti-diabetes principle; results of clinical research].

Authors: H FRANKE; J FUCHS
Journal: Dtsch Med Wochenschr Date: 1955-10-07 Impact factor: 0.628

4. [Stimulation of insulin secretion in vitro by a new, highly-active antidiabetic].

Authors: H Schwarz; J Ammon; J E Yeboah; H E Hildebrandt; E F Pfeiffer
Journal: Diabetologia Date: 1968-01 Impact factor: 10.122

5. The pattern of rsponse of plasma insulin and glucose to meals and fasting during chlorpropamide therapy.

Authors: P C Chu; M J Conway; H A Krouse; C J Goodner
Journal: Ann Intern Med Date: 1968-04 Impact factor: 25.391

6. Clinical experience with glibenclamide in 300 diabetics.

Authors: J Beyer; K Schöffling
Journal: Postgrad Med J Date: 1970-12 Impact factor: 2.401

7. [Oral antidiabetic monotherapy and combination treatment with glybenclamide (HB 419) and biguanides of insulin receiving diabetics of the adult type].

Authors: B Knick; O Wendt; M L Konder; P Netter
Journal: Med Klin Date: 1970-01-16

8. [Glybenclamide (HB 419): a new oral antidiabetic agent of the sulfonylurea group].

Authors: H Mehnert; E Karg
Journal: Dtsch Med Wochenschr Date: 1969-04-18 Impact factor: 0.628

9. [Progress in diabetes therapy using glibenclamide and phenformin. Report from the years 1967-1970 on 323 patients].

Authors: J Beyer; W Ewald; W Kunkel; E Wolf; K Schöffling
Journal: Dtsch Med Wochenschr Date: 1971-04-23 Impact factor: 0.628

10. Glibenclamide therapy in diabetes mellitus.

Authors: S K Bhattia; D R Hadden; D A Montgomery; J A Weaver
Journal: Br Med J Date: 1970-06-06

10 in total

6 in total

1. Extrapancreatic and pancreatic actions of glibenclamide in rats.

Authors: W Heptner; A Zermatten; H M Kellner; O Christ; J P Felber
Journal: Diabetologia Date: 1977-08 Impact factor: 10.122

2. Pharmacokinetics of intravenous glibenclamide investigated by a high performance liquid chromatographic assay.

Authors: H J Rogers; R G Spector; P J Morrison; I D Bradbrook
Journal: Diabetologia Date: 1982-07 Impact factor: 10.122

3. Effects of a xanthine derivative (BL 191) on insulin secretion in normal man.

Authors: G Lenti; G Pagano; G Angotzi; A B Sani; A Diana
Journal: Eur J Clin Pharmacol Date: 1975-12-19 Impact factor: 2.953

4. 24-h blood glucose pattern in type I and type II diabetics after oral treatment with pentoxifylline as assessed by artificial endocrine pancreas.

Authors: S Raptis; A Mitrakou; D Hadjidakis; E Diamantopoulos; C Anastasiou; A Fountas; R Müller
Journal: Acta Diabetol Lat Date: 1987 Jul-Sep

5. Blood glucose and serum insulin levels following acute and chronic pentoxifylline administration.

Authors: H Heidrich; T Schirop
Journal: Acta Diabetol Lat Date: 1980 Jan-Mar

6. Effects of pentoxifylline on proteinuria and glucose control in patients with type 2 diabetes: a prospective randomized double-blind multicenter study.

Authors: Seung Jin Han; Hae Jin Kim; Dae Jung Kim; Seung Soo Sheen; Choon Hee Chung; Chul Woo Ahn; Se Hwa Kim; Yong-Wook Cho; Seok Won Park; Soo-Kyung Kim; Chul Sik Kim; Kyung Wook Kim; Kwan Woo Lee
Journal: Diabetol Metab Syndr Date: 2015-07-19 Impact factor: 3.320

6 in total